Articles

  • 1 week ago | clpmag.com | Chris Wolski

    Summary:The March/April 2025 issue of Clinical Lab Products features a comprehensive Tech Guide highlighting products from seven leading laboratory providers, alongside spotlights on COVID-19 and point-of-care technologies. • The Tech Guide allows readers to compare lab products side-by-side from companies like Bio-Rad, Randox, and ZeptoMetrix. • Product Spotlights and Tech Guide listings are published at no cost, complete with company contact details.

  • 1 week ago | clpmag.com | Chris Wolski

    Summary:Accelerate Diagnostics has filed for Chapter 11 bankruptcy and plans to sell its assets through a court-supervised process, supported by DIP financing and a stalking horse bid from Indaba Capital. • Stalking Horse Bid: Indaba Capital, a major creditor, has agreed to purchase most of the company’s assets for $36.9 million through a credit bid and assumed liabilities.

  • 1 week ago | clpmag.com | Chris Wolski

    ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial for a more automated version, reinforcing its leadership in gastrointestinal diagnostics. • Diagnostic Accuracy: With over 90% sensitivity and specificity, the assay aids in distinguishing IBD from IBS. • Automation Advancement: A U.S. clinical trial is underway for a chemiluminescent version aimed at improving lab efficiency.

  • 1 week ago | clpmag.com | Chris Wolski

    Summary:Leica Microsystems has launched Aivia 15, an enhanced AI-driven image analysis software designed to simplify and accelerate scientific microscopy workflows through improved usability, performance, and accessibility. • User-Friendly Design: Aivia 15 introduces intuitive tools like Segment by Example and Aivia Launchpad to enable non-coders to perform powerful AI-based analysis easily.

  • 1 week ago | clpmag.com | Chris Wolski

    Summary:Nordic Bioscience’s PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a validated and CE-approved method to assess liver fibrosis severity using the Elecsys platform. • The PRO-C3 biomarker, now CE-approved and globally available via Roche’s cobas analyzers, aids in evaluating liver fibrosis using the ADAPT formula. • The test has been clinically validated in Nordic Bioscience’s certified lab and backed by over 250 scientific publications.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →